Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,356,139 papers from all fields of science
Search
Sign In
Create Free Account
Sulfinpyrazone
Known as:
Sulphinpyrazone
, 3,5-Pyrazolidinedione, 1,2-diphenyl-4-(2-(phenylsulfinyl)ethyl)-
, Sulfoxyphenylpyrazolidine
Expand
A phenylbutazone derivative with uricosuric and antithrombotic properties. Sulfinpyrazone competitively inhibits reabsorption of urate at the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
20 relations
Angina Pectoris
Antipyrine
Coronary heart disease
Drug Allergy
Expand
Narrower (2)
Anturane
G 25671
Broader (1)
Uricosuric Agents
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts.
N. Tanner
,
A. Da Silva
Cochrane Database of Systematic Reviews
2015
Corpus ID: 205166967
BACKGROUND End-stage renal disease (ESRD) patients often require either the formation of an arteriovenous (AV) fistula or an AV…
Expand
Highly Cited
1996
Highly Cited
1996
Ascorbate Uptake by Microvascular Endothelial Cells of Rat Skeletal Muscle
John X. Wilson
,
S. J. Dixon
,
J. Yu
,
S. Nees
,
K. Tyml
Microcirculation
1996
Corpus ID: 31142370
Objective: In several systems, exogenous ascorbate (reduced vitamin C) has been shown to protect against microvascular injury…
Expand
Review
1988
Review
1988
Trends in physician management of uncomplicated acute myocardial infarction, 1970 to 1987.
M. Hlatky
,
H. Cotugno
,
D. Mark
,
C. O'connor
,
R. Califf
,
D. Pryor
American Journal of Cardiology
1988
Corpus ID: 1051065
Review
1987
Review
1987
The St. Jude Medical cardiac valve in infants and children: role of anticoagulant therapy.
M. Schaffer
,
D. Clarke
,
D. Campbell
,
C. Madigan
,
J. Wiggins
,
R. Wolfe
Journal of the American College of Cardiology
1987
Corpus ID: 45965604
Highly Cited
1987
Highly Cited
1987
The amplified chemiluminescence test to characterize antirheumatic drugs as oxygen radical scavengers.
Reiner Muller-Peddinghaus
,
Michael Wurl
Biochemical Pharmacology
1987
Corpus ID: 42342100
1982
1982
In Vivo Platelet Activation Following Myocardial Infarction and Acute Coronary Ischaemia
A. Hughes
,
S. Daunt
,
G. Vass
,
J. Wickes
Thrombosis and Haemostasis
1982
Corpus ID: 13345902
Summary Forty-seven patients presenting with acute chest pain had in vivo platelet activity assessed by measuring plasma levels…
Expand
Highly Cited
1979
Highly Cited
1979
The Effect of Agents which Modify Platelet Behaviour and of Magnesium Ions on Thrombus Formation In Vivo
J. Adams
,
J. Mitchell
Thrombosis and Haemostasis
1979
Corpus ID: 38524309
Summary The ability of potential anti-thrombotic agents to modify platelet-thrombus formation in injured cerebral arteries in the…
Expand
Highly Cited
1978
Highly Cited
1978
EFFECTS OF SULPHINPYRAZONE AND ASPIRIN ON PROSTAGLANDIN I2 (PROSTACYCLIN) SYNTHESIS BY ENDOTHELIAL CELLS
J. L. Gordon
,
J. Pearson
British Journal of Pharmacology
1978
Corpus ID: 41936504
Synthesis of prostaglandin I2, (PGI2, prostacyclin) by vascular endothelium (assayed by the ability of cultured endothelial cells…
Expand
Highly Cited
1975
Highly Cited
1975
The Role of Sulfinpyrazone in the Prevention of Arterio‐venous Shunt Thrombosis
A. Kaegi
,
G. Pineo
,
A. Shimizu
,
H. Trivedi
,
J. Hirsh
,
M. Gent
Circulation
1975
Corpus ID: 5736255
The effect of sulfinpyrazone on the incidence of thrombosis of arterio-venous shunts was investigated in a double-blind crossover…
Expand
Highly Cited
1967
Highly Cited
1967
The effect of sulfinpyrazone on platelet economy and thrombus formation in rabbits.
J. Mustard
,
H. Rowsell
,
H. Smythe
,
A. Sényi
,
E. Murphy
Blood
1967
Corpus ID: 847931
Platelet survival was prolonged in rabbits which had been on sulfinpyrazone for 30 days or more. This was not accompanied by…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required